Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PURA | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | GNS | FIMM | pan-cancer | AAC | 0.48 | 0.01 |
mRNA | TSPY3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | BRD8 | FIMM | pan-cancer | AAC | -0.44 | 0.01 |
mRNA | CORIN | FIMM | pan-cancer | AAC | 0.44 | 0.01 |
mRNA | PROSER3 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | SMOC2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | QPCT | FIMM | pan-cancer | AAC | -0.45 | 0.01 |
mRNA | KRR1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | VPS4B | CCLE | pan-cancer | AAC | 0.12 | 0.01 |